These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 8616836

  • 1. Uptake of temozolomide in a rat glioma model in the presence and absence of the angiogenesis inhibitor TNP-470.
    Devineni D, Klein-Szanto A, Gallo JM.
    Cancer Res; 1996 May 01; 56(9):1983-7. PubMed ID: 8616836
    [Abstract] [Full Text] [Related]

  • 2. Pharmacodynamic-mediated reduction of temozolomide tumor concentrations by the angiogenesis inhibitor TNP-470.
    Ma J, Pulfer S, Li S, Chu J, Reed K, Gallo JM.
    Cancer Res; 2001 Jul 15; 61(14):5491-8. PubMed ID: 11454697
    [Abstract] [Full Text] [Related]

  • 3. Preclinical pharmacokinetic and pharmacodynamic evaluation of metronomic and conventional temozolomide dosing regimens.
    Zhou Q, Guo P, Wang X, Nuthalapati S, Gallo JM.
    J Pharmacol Exp Ther; 2007 Apr 15; 321(1):265-75. PubMed ID: 17259446
    [Abstract] [Full Text] [Related]

  • 4. Microdialysis measurement of intratumoral temozolomide concentration after cediranib, a pan-VEGF receptor tyrosine kinase inhibitor, in a U87 glioma model.
    Grossman R, Tyler B, Rudek MA, Kim E, Zadnik P, Khan U, Blakeley JO, Pathak AP, Brem H.
    Cancer Chemother Pharmacol; 2013 Jul 15; 72(1):93-100. PubMed ID: 23649683
    [Abstract] [Full Text] [Related]

  • 5. Metronomic treatment of temozolomide inhibits tumor cell growth through reduction of angiogenesis and augmentation of apoptosis in orthotopic models of gliomas.
    Kim JT, Kim JS, Ko KW, Kong DS, Kang CM, Kim MH, Son MJ, Song HS, Shin HJ, Lee DS, Eoh W, Nam DH.
    Oncol Rep; 2006 Jul 15; 16(1):33-9. PubMed ID: 16786120
    [Abstract] [Full Text] [Related]

  • 6. Pharmacodynamic-mediated effects of the angiogenesis inhibitor SU5416 on the tumor disposition of temozolomide in subcutaneous and intracerebral glioma xenograft models.
    Ma J, Li S, Reed K, Guo P, Gallo JM.
    J Pharmacol Exp Ther; 2003 Jun 15; 305(3):833-9. PubMed ID: 12626639
    [Abstract] [Full Text] [Related]

  • 7. Combination treatment with temozolomide and thalidomide inhibits tumor growth and angiogenesis in an orthotopic glioma model.
    Son MJ, Kim JS, Kim MH, Song HS, Kim JT, Kim H, Shin T, Jeon HJ, Lee DS, Park SY, Kim YJ, Kim JH, Nam DH.
    Int J Oncol; 2006 Jan 15; 28(1):53-9. PubMed ID: 16327979
    [Abstract] [Full Text] [Related]

  • 8. Impact of angiogenesis inhibition by sunitinib on tumor distribution of temozolomide.
    Zhou Q, Guo P, Gallo JM.
    Clin Cancer Res; 2008 Mar 01; 14(5):1540-9. PubMed ID: 18316579
    [Abstract] [Full Text] [Related]

  • 9. Differential effect of sunitinib on the distribution of temozolomide in an orthotopic glioma model.
    Zhou Q, Gallo JM.
    Neuro Oncol; 2009 Jun 01; 11(3):301-10. PubMed ID: 18971416
    [Abstract] [Full Text] [Related]

  • 10. Temozolomide inhibits cellular growth and motility via targeting ERK signaling in glioma C6 cells.
    Wang Y, Gao S, Wang W, Liang J.
    Mol Med Rep; 2016 Dec 01; 14(6):5732-5738. PubMed ID: 27878252
    [Abstract] [Full Text] [Related]

  • 11. Anti-proliferative effects of TNP-470 on human malignant glioma in vivo: potent inhibition of tumor angiogenesis.
    Taki T, Ohnishi T, Arita N, Hiraga S, Saitoh Y, Izumoto S, Mori K, Hayakawa T.
    J Neurooncol; 1994 Dec 01; 19(3):251-8. PubMed ID: 7807176
    [Abstract] [Full Text] [Related]

  • 12. Enhanced suppression of tumor growth by combination of angiogenesis inhibitor O-(chloroacetyl-carbamoyl)fumagillol (TNP-470) and cytotoxic agents in mice.
    Kato T, Sato K, Kakinuma H, Matsuda Y.
    Cancer Res; 1994 Oct 01; 54(19):5143-7. PubMed ID: 7522956
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of tumor growth and microvascular angiogenesis by the potent angiogenesis inhibitor, TNP-470, in rats.
    Niwano M, Arii S, Mori A, Ishigami S, Harada T, Mise M, Furutani M, Fujioka M, Imamura M.
    Surg Today; 1998 Oct 01; 28(9):915-22. PubMed ID: 9744400
    [Abstract] [Full Text] [Related]

  • 14. β-Asarone promotes Temozolomide's entry into glioma cells and decreases the expression of P-glycoprotein and MDR1.
    Wang N, Zhang Q, Ning B, Luo L, Fang Y.
    Biomed Pharmacother; 2017 Jun 01; 90():368-374. PubMed ID: 28380412
    [Abstract] [Full Text] [Related]

  • 15. Antitumor effect of TNP-470 on glial tumors transplanted in rats.
    Isobe N, Uozumi T, Kurisu K, Kawamoto K.
    Anticancer Res; 1996 Jun 01; 16(1):71-6. PubMed ID: 8615672
    [Abstract] [Full Text] [Related]

  • 16. Combination of photodynamic therapy and temozolomide on glioma in a rat C6 glioma model.
    Zhang X, Guo M, Shen L, Hu S.
    Photodiagnosis Photodyn Ther; 2014 Dec 01; 11(4):603-12. PubMed ID: 25449156
    [Abstract] [Full Text] [Related]

  • 17. Trans-1-amino-3-18F-fluorocyclobutanecarboxylic acid (anti-18F-FACBC) is a feasible alternative to 11C-methyl-L-methionine and magnetic resonance imaging for monitoring treatment response in gliomas.
    Sasajima T, Ono T, Shimada N, Doi Y, Oka S, Kanagawa M, Baden A, Mizoi K.
    Nucl Med Biol; 2013 Aug 01; 40(6):808-15. PubMed ID: 23701701
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of tumor growth and metastasis of rodent tumors by the angiogenesis inhibitor O-(chloroacetyl-carbamoyl)fumagillol (TNP-470; AGM-1470).
    Yamaoka M, Yamamoto T, Masaki T, Ikeyama S, Sudo K, Fujita T.
    Cancer Res; 1993 Sep 15; 53(18):4262-7. PubMed ID: 7689930
    [Abstract] [Full Text] [Related]

  • 19. Effectiveness of the angiogenesis inhibitor TNP-470 in reducing the growth of human neuroblastoma in nude mice inversely correlates with tumor burden.
    Katzenstein HM, Rademaker AW, Senger C, Salwen HR, Nguyen NN, Thorner PS, Litsas L, Cohn SL.
    Clin Cancer Res; 1999 Dec 15; 5(12):4273-8. PubMed ID: 10632370
    [Abstract] [Full Text] [Related]

  • 20. Combined effects of temozolomide and the ribonucleotide reductase inhibitors didox and trimidox in malignant brain tumor cells.
    Figul M, Söling A, Dong HJ, Chou TC, Rainov NG.
    Cancer Chemother Pharmacol; 2003 Jul 15; 52(1):41-6. PubMed ID: 12690517
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.